diff --git a/_atlas-datasets/Generating-and-incorporating-ovarian-cancer-data-to-Gray-Foundation-pre-cancer-BRCA-Atlas.md b/_atlas-datasets/Generating-and-incorporating-ovarian-cancer-data-to-Gray-Foundation-pre-cancer-BRCA-Atlas.md index 81ce6ac..8bd2d57 100644 --- a/_atlas-datasets/Generating-and-incorporating-ovarian-cancer-data-to-Gray-Foundation-pre-cancer-BRCA-Atlas.md +++ b/_atlas-datasets/Generating-and-incorporating-ovarian-cancer-data-to-Gray-Foundation-pre-cancer-BRCA-Atlas.md @@ -8,7 +8,7 @@ data: title: Investigating the origins and early diagnosis of ovarian cancer description: "Ovarian cancer is more deadly on a per case basis than breast cancer and has witnessed fewer advances in treatment or diagnosis. In the US, 20,000 new diagnoses and 14,000 deaths from ovarian cancer are recorded per year; this contrasts with 240,00 new cases of breast cancer and 42,000 deaths. Like breast cancer, ovarian cancer is much more frequent in individuals who carry mutations in the BRCA1 or BRAC2 genes (an~1.2% vs 40% lifetime risk). Thus, BRCA1/2 carriers face the terrible choice of living with a high risk of cancer or undergoing surgery to remove healthy ovaries and fallopian tubes (risk-reducing salpingo-oophorectomy). - One factor making the risk reduction decisions harder is that diagnosis of ovarian cancer is typically made late and the origins of the disease are poorly understood; this is also true of ovarian cancer in individuals who are not BRAC1/2 carriers. It has been discovered relatively recently that some epithelial ovarian cancers may arise in the fallopian tube, from a pre-cancerous lesion know as a serous tubal intraepithelial carcinoma (STIC). The goal of our project is to better characterize the biology of STICs to understand its clinical significance and develop precise criteria for diagnosing STICs in surgical samples. This is being performed using a range of genomic and spatial profiling tools that are expected to generate a data atlas as early as 2024. We expect these data to significantly impact how we treat people at risk for this terrible disease." + One factor making the risk reduction decisions harder is that diagnosis of ovarian cancer is typically made late and the origins of the disease are poorly understood; this is also true of ovarian cancer in individuals who are not BRAC1/2 carriers. It has been discovered relatively recently that some epithelial ovarian cancers may arise in the fallopian tube, from a pre-cancerous lesion know as a serous tubal intraepithelial carcinoma (STIC). The goal of our project is to better characterize the biology of STICs to understand its clinical significance and develop precise criteria for diagnosing STICs in surgical samples. This is being performed using a range of genomic and spatial profiling tools that are expected to generate a data atlas as early as 2024. We expect these data to significantly impact how we treat people at risk for this terrible disease." --- @@ -21,11 +21,17 @@ data: thumbnailDir=sectionId %} ### Contents +* [Project Overview Video](#project-overview) * [Data Stories](#data-stories) * [Explore Tissue Images](#explore-tissue-images) +## Project Overview +
+ {% include vimeo-card.html id="866120650" title="Ovarian Cancer Atlas with Dr. Ronny Drapkin and Dr. Tanjina Kader" %} +
+ ## Data Stories -**Data Stories are narrated Minerva stories that guide readers through the complexities of a large image dataset via a series of progressive narrated waypoints.** +Data Stories are narrated Minerva stories that guide readers through the complexities of a large image dataset via a series of progressive narrated waypoints. {% assign overviews = site.data-cards @@ -39,7 +45,7 @@ data: {% endif %} ## Explore Tissue Images -**Access the minimally processed, unannotated Level 2 images associated with this publication. Click any of the following thumbnail images for an interactive view of the full-resolution images.** +Access the minimally processed, unannotated Minerva stores of additional tissue images associated with this project. Click any of the following thumbnail images for an interactive view of the full-resolution images. {% assign overviews = site.data-cards diff --git a/_people/conrad-christina.md b/_people/conrad-christina.md index 96fefe2..a69097b 100644 --- a/_people/conrad-christina.md +++ b/_people/conrad-christina.md @@ -10,5 +10,5 @@ photo: people/conrad-christina.png group: dcc -weight: 10 +weight: 30 --- diff --git a/_people/corrigan-kimberly.md b/_people/corrigan-kimberly.md index e9aafc9..e5e0361 100644 --- a/_people/corrigan-kimberly.md +++ b/_people/corrigan-kimberly.md @@ -11,5 +11,5 @@ photo: people/corrigan-kimberly.png group: dcc -weight: 40 +weight: 50 --- diff --git a/_people/de-bruijn-ino.md b/_people/de-bruijn-ino.md index 60c674f..cf0ee30 100644 --- a/_people/de-bruijn-ino.md +++ b/_people/de-bruijn-ino.md @@ -11,5 +11,5 @@ photo: people/de-bruijn-ino.png group: dcc -weight: 50 +weight: 70 --- diff --git a/_people/mitraka-elvira.md b/_people/mitraka-elvira.md index 0fbf14c..c8c69b0 100644 --- a/_people/mitraka-elvira.md +++ b/_people/mitraka-elvira.md @@ -11,5 +11,5 @@ photo: people/mitraka-elvira.png group: dcc -weight: 30 +weight: 20 --- diff --git a/_people/morin-pat.md b/_people/morin-pat.md index c32fe29..ea79525 100644 --- a/_people/morin-pat.md +++ b/_people/morin-pat.md @@ -11,5 +11,5 @@ photo: people/morin-pat.png group: directors -weight: 10 +weight: 20 --- diff --git a/_people/schultz-nikolaus.md b/_people/schultz-nikolaus.md index 5fcadf2..41b4739 100644 --- a/_people/schultz-nikolaus.md +++ b/_people/schultz-nikolaus.md @@ -7,5 +7,5 @@ photo: people/schultz-nikolaus.jpg group: dcc -weight: 10 +weight: 60 --- diff --git a/_people/vu-anh-nguyet.md b/_people/vu-anh-nguyet.md index 96ff446..e315519 100644 --- a/_people/vu-anh-nguyet.md +++ b/_people/vu-anh-nguyet.md @@ -10,5 +10,5 @@ photo: people/vu-anh-nguyet.png group: dcc -weight: 20 +weight: 40 ---